Position in GILD
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$12,996,090
-$24,305,733 QoQ
Shares Held
102,866
-61.6% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#388
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ACADIAN ASSET MANAGEMENT LLC holds $3,615,172,375 across 15 Drug Manufacturers - General names. GILD ranks #11 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMY |
Bristol Myers Squibb Co
|
11,593,352 | $668,008,942 | |
| 2 | LLY |
ELI LILLY & Co
|
508,522 | $609,936,593 | |
| 3 | ABBV |
AbbVie Inc.
|
1,901,997 | $478,618,525 | |
| 4 | MRK |
Merck & Co., Inc.
|
3,695,329 | $474,849,776 | |
| 5 | AZN |
Astrazeneca PLC
|
2,262,369 | $428,990,409 | |
| 6 | GSK |
GSK plc
|
6,660,434 | $349,139,950 | |
| 7 | JNJ |
Johnson & Johnson
|
1,361,700 | $345,830,949 | |
| 8 | NVO |
Novo Nordisk A S
|
2,736,697 | $131,197,254 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,996,090 | 102,866 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $37,301,823 | 267,646 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $107,677,960 | 877,285 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $85,412,613 | 769,483 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $85,131,972 | 767,854 | Shares | Defined | 2025-08-07 | |
| 2025-03-31 | $44,313,534 | 395,480 | Shares | Defined | 2025-05-21 | |
| 2024-12-31 | $19,019,999 | 205,911 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $18,575,758 | 221,562 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $19,805,168 | 288,663 | Shares | Defined | 2024-08-06 | |
| 2024-03-31 | $25,002,935 | 341,337 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $54,030,591 | 666,962 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $63,082,918 | 841,779 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $134,755,816 | 1,748,486 | Shares | Defined | 2023-08-07 | |
| 2023-03-31 | $150,043,694 | 1,808,409 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $166,370,260 | 1,937,918 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $139,034,824 | 2,253,766 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $129,868,805 | 2,101,097 | Shares | Defined | 2022-08-09 | |
| 2022-03-31 | $125,150,691 | 2,105,142 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $41,625,715 | 573,278 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $95,174,676 | 1,362,558 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $178,481,608 | 2,591,949 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $159,623,367 | 2,469,803 | Shares | Defined | 2021-05-11 | |
| 2020-12-31 | $134,674,981 | 2,311,620 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $142,331,051 | 2,252,430 | Shares | Defined | 2020-11-09 | |
| 2020-06-30 | $113,676,464 | 1,477,469 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $61,865,619 | 827,523 | Shares | Defined | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||